- Home
- BPMC vs CHRD Comparison
BPMC vs CHRD Comparison
Compare BPMC & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- CHRD
- Stock Information
- Founded
- BPMC 2008
- CHRD 2007
- Country
- BPMC United States
- CHRD United States
- Employees
- BPMC N/A
- CHRD N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- CHRD Oil & Gas Production
- Sector
- BPMC Health Care
- CHRD Energy
- Exchange
- BPMC Nasdaq
- CHRD Nasdaq
- Market Cap
- BPMC 8.3B
- CHRD 5.9B
- IPO Year
- BPMC 2015
- CHRD 2010
- Fundamental
- Price
- BPMC $129.35
- CHRD $104.09
- Analyst Decision
- BPMC Buy
- CHRD Buy
- Analyst Count
- BPMC 20
- CHRD 12
- Target Price
- BPMC $127.82
- CHRD $150.83
- AVG Volume (30 Days)
- BPMC 3.3M
- CHRD 823.2K
- Earning Date
- BPMC 07-31-2025
- CHRD 08-06-2025
- Dividend Yield
- BPMC N/A
- CHRD 6.39%
- EPS Growth
- BPMC N/A
- CHRD N/A
- EPS
- BPMC N/A
- CHRD 15.19
- Revenue
- BPMC $562,121,000.00
- CHRD $5,036,741,000.00
- Revenue This Year
- BPMC $44.46
- CHRD N/A
- Revenue Next Year
- BPMC $32.78
- CHRD N/A
- P/E Ratio
- BPMC N/A
- CHRD $6.86
- Revenue Growth
- BPMC 99.19
- CHRD 31.78
- 52 Week Low
- BPMC $73.04
- CHRD $79.83
- 52 Week High
- BPMC $129.49
- CHRD $181.17
- Technical
- Relative Strength Index (RSI)
- BPMC 76.77
- CHRD 53.50
- Support Level
- BPMC $129.00
- CHRD $104.79
- Resistance Level
- BPMC $129.47
- CHRD $109.64
- Average True Range (ATR)
- BPMC 0.25
- CHRD 3.07
- MACD
- BPMC -0.88
- CHRD 0.18
- Stochastic Oscillator
- BPMC 90.21
- CHRD 58.55
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is developing medicines in the following focus areas; allergy, inflammation, oncology, and hematology. Its approved medicines, including Avyakit and Avyakyt, are given to patients living with systemic mastocytosis (SM) and PDGFRA Exon 18 mutant GIST in the U.S. and Europe. The company also has various other drug candidates in its pipeline such as BLU-808, BLU-222, BLU-956, and others that are being developed to treat mast cell diseases including SM and chronic urticaria, breast cancer, and other solid tumors. Geographically, it operates in the United States, which is its key revenue market, and Europe.
About CHRD Chord Energy Corporation
Chord Energy Corp is an independent exploration and production company. The company acquires, exploits, develops, and explores crude oil, natural gas, and natural gas liquids in the Williston Basin.